- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Endocrinology
Volume 2012 (2012), Article ID 503290, 4 pages
Adrenal Incidentalomas with Supraphysiologic Response to ACTH Stimulus: A Case Report
1SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1205, Brooklyn, NY 11203, USA
2VA Medical Center, 800 Poly Place, New York, NY 11209, USA
Received 7 August 2012; Accepted 20 September 2012
Academic Editors: I. Broom, C. Capella, and T. Konrad
Copyright © 2012 Marianna Antonopoulou and Asya Perelstein. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- E. Vassilatou, A. Vryonidou, S. Michalopoulou et al., “Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study,” Clinical Endocrinology, vol. 70, no. 5, pp. 674–679, 2009.
- L. Tauchmanovà, R. Rossi, B. Biondi et al., “Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 4872–4878, 2002.
- J. D. Amsterdam, A. Winokur, E. Abelman, I. Lucki, and K. Rickels, “Cosyntropin (ACTH α1-24) stimulation test in depressed patients and healthy subjects,” American Journal of Psychiatry, vol. 140, no. 7, pp. 907–909, 1983.
- M. Terzolo, S. Bovio, G. Reimondo et al., “Subclinical Cushing's syndrome in adrenal incidentalomas,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 423–439, 2005.
- L. K. Nieman, B. M. Biller, J. W. Findling, et al., “The diagnosis of Cushing's syndrome: an endocrien society, clinical practice guideline,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1526–1540, 2008.
- D. W. Hudgel, E. A. Gordon, and H. Y. Meltzer, “Abnormal serotonergic stimulation of cortisol production in obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 1, pp. 186–192, 1995.
- F. Besemer, A. M. Pereira, and J. W. A. Smit, “Alcohol-induced Cushing syndrome: hypercortisolism caused by alcohol abuse,” Netherlands Journal of Medicine, vol. 69, no. 7, pp. 318–323, 2011.
- A. Lacroix and I. Bourdeau, “Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 441–458, 2005.
- A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet, “Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome,” Endocrine Reviews, vol. 22, no. 1, pp. 75–110, 2001.
- H. P. Hsiao, L. S. Kirschner, I. Bourdeau et al., “Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 8, pp. 2930–2937, 2009.
- I. Bourdeau, P. D'Amour, P. Hamet, J. M. Boutin, and A. Lacroix, “Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 11, pp. 5534–5540, 2001.
- S. R. Antonini, V. Baldacchino, J. Tremblay, P. Hamet, and A. Lacroix, “Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome,” Clinical Endocrinology, vol. 64, no. 1, pp. 29–36, 2006.
- M. Aiba, A. Hirayama, H. Iri, et al., “Adrenocorticotropic hormone independent bilateral adrenocortical macronodular hyperplasia as a dinstinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of literature,” American Journal of Clinical Pathology, vol. 96, pp. 334–340, 1991.
- I. Chiodini, “Diagnosis and treatment of subclinical hypercortisolism,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1223–1236, 2011.
- J. L. Doppman, L. K. Nieman, W. D. Travis et al., “CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism,” Journal of Computer Assisted Tomography, vol. 15, no. 5, pp. 773–779, 1991.
- A. Lacroix, J. Tremblay, G. Rousseau, M. Bouvier, and P. Hamet, “Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing's syndrome,” New England Journal of Medicine, vol. 337, no. 20, pp. 1429–1434, 1997.
- A. Toniato, I. Merante-Boschin, G. Opocher, M. R. Pelizzo, F. Schiavi, and E. Ballotta, “Surgical versus conservative management for subclinical cushing syndrome in adrenal incidentalomas: a prospective randomized study,” Annals of Surgery, vol. 249, no. 3, pp. 388–391, 2009.
- Y. Li, Y. K. Guo, Z. G. Yang, E. S. Ma, and P. Q. Min, “Extramedullary plasmacytoma involving the bilateral adrenal glands on MR imaging,” Korean Journal of Radiology, vol. 8, no. 3, pp. 246–248, 2007.
- S. Fujikata, N. Tanji, K. Aoki, H. Ohoka, N. Hojo, and M. Yokoyama, “Extramedullary plasmacytoma arising from an adrenal gland,” Urology, vol. 60, no. 3, p. 514, 2002.
- T. Kahara, Y. Nagai, H. Yamashita, E. Nohara, K. Kobayashi, and T. Takamura, “Extramedullary plasmatocytoma in the adrenal incidentaloma,” Clinical Endocrinology, vol. 55, no. 2, pp. 267–270, 2001.